Pharma Blister Packaging Machines Market Hits USD 3.13 Bn by 2034

Pharma Blister Packaging Machines Market Intelligence, Benchmarking, Consumer Insights & Growth Strategies

The pharma blister packaging machines market is set to grow from USD 2.37 billion in 2024 to USD 3.13 billion by 2034, expanding at a CAGR of 2.85% from 2025 to 2034. North America led the market in 2024, while Europe is expected to witness significant growth during the forecast period.

Content

TOC is not Available for this Report

  • Insight Code: 5457
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: February 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a dynamic market research professional with over three years of expertise in healthcare packaging and advanced packaging material solutions. His in-depth understanding of the healthcare packaging sector encompasses a broad range of areas, including regulatory compliance, material innovation, and sustainable packaging solutions. Rohan is passionate about driving innovation in packaging technologies, ensuring that healthcare products are safely delivered while meeting evolving environmental and industry standards.

Throughout his career, Rohan has collaborated with key players in the healthcare and packaging industries, conducting detailed research on emerging trends, material advancements, and consumer preferences. His expertise includes advanced packaging materials such as smart packaging, temperature-sensitive solutions, and tamper-evident technologies, all of which are becoming increasingly important in safeguarding healthcare products and ensuring patient safety.

Rohan's market research reports provide businesses with valuable insights into the latest technological innovations, regulatory shifts, and market dynamics in healthcare packaging. His work helps companies refine their strategies, optimize packaging designs, and adopt cutting-edge materials that align with sustainability goals and industry standards.

Talk to us next-arrow
FAQ's

The global pharma blister packaging machines market size reached US$ 2.37 billion in 2024 and is projected to hit around US$ 3.13 billion by 2034.

North America dominated the global pharma blister packaging machines market in 2024, driven by its well-developed pharmaceutical infrastructure, high healthcare expenditure, and presence of major pharmaceutical companies like Pfizer and Johnson & Johnson.

Industry 4.0 Integration: Adoption of automation, robotics, and AI for efficient and precise packaging. Eco-Friendly Packaging: Rising demand for recyclable and biodegradable blister packaging materials. Customization: Increasing need for flexible machines to handle small-batch and personalized medicine packaging. Enhanced Product Protection: Innovations in blister packaging to improve tamper-evidence and child-resistant features.

Predictive Maintenance: Reducing downtime by predicting machine failures. Quality Control: Enhancing defect detection and ensuring compliance with GMP standards. Energy Efficiency: Optimizing energy consumption for sustainable operations. Regulatory Compliance: Automating documentation and audit trails for better traceability.

E-Commerce Expansion: Rising demand for tamper-proof and secure packaging for online pharmacies. Sustainability: Development of machines compatible with eco-friendly materials. Personalized Medicine: Increasing need for flexible machines to handle small-batch productions.

The automatic segment dominated the market in 2024 due to its high production rates, accuracy, and cost-efficiency, making it ideal for large-scale pharmaceutical manufacturing.

The thermoforming segment accounted for a significant share of the market in 2024, as it offers customization, cost-efficiency, and excellent product protection, making it ideal for pharmaceutical packaging.

The 201 to 600 blisters/min segment dominated the market in 2024 and is expected to maintain its lead due to its balance of speed, cost-effectiveness, and adaptability for medium to high production scales.

Körber AG, Romaco Group, NJM Packaging, Pharmaworks LLC, O.M.A.R. S.r.l., Mediseal GmbH, Titan Pharmaceutical Machinery, Zhejiang Jiangnan Pharmaceutical Machinery Co., Ltd.

Slower Adoption in Emerging Markets: Due to infrastructure and funding limitations. Supply Chain Disruptions: Delays in sourcing raw materials and components. High Penetration in Mature Markets: Limited growth opportunities in regions like North America and Europe.

Europe is expected to grow at a significant rate due to: A thriving pharmaceutical sector with companies like Novartis and Roche. A focus on sustainability and eco-friendly packaging solutions. High automation rates (67.8% automated industrial sector) driving demand for advanced blister packaging machines.

Pharmaworks’ TF1e Blister Machine: Upgraded with features for handling recyclable materials and deeper thermoforming. Uhlmann’s Expansion in India: New office in Pune to strengthen operations in the Indian market. Ropack Pharma Solutions: Investments in advanced machinery and automation for enhanced production capabilities.

The main components of blister packaging machine consists of a lid feeding mechanism, product feeding system, heating station, cutting station, sealing station, shaping station, and film feeder.

In thermoforming, the cavities are made by heating a plastic sheet, but in cold forming, the blister shape is formed without heat using a pre-formed mold.

Drug and Pharmaceutical Packaging Committee, China National Pharmaceutical Packaging Association, PMMI, The Association for Packaging and Processing Technology, Packaging Industry Association of India: PIAI, World Packaging Organisation, AIPIA | Active & Intelligent Packaging Industry Association, Indian Pharmaceutical Alliance | Pharma Alliance in India and Organisation of Pharmaceutical Producers of India (OPPI) among others.
Any Questions